Skip to main page content (VSports app下载)
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site VSports app下载. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2010 Jan 18;207(1):17-27.
doi: 10.1084/jem.20091619. Epub 2009 Dec 21.

Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning

Trung H M Pham  1 , Peter Baluk, Ying Xu, Irina Grigorova, Alex J Bankovich, Rajita Pappu, Shaun R Coughlin, Donald M McDonald, Susan R Schwab, Jason G Cyster
Affiliations

Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning

Trung H M Pham et al. J Exp Med. .

Abstract (V体育平台登录)

Lymphocyte egress from lymph nodes (LNs) is dependent on sphingosine-1-phosphate (S1P), but the cellular source of this S1P is not defined. We generated mice that expressed Cre from the lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1) locus and that showed efficient recombination of loxP-flanked genes in lymphatic endothelium VSports手机版. We report that mice with Lyve-1 CRE-mediated ablation of sphingosine kinase (Sphk) 1 and lacking Sphk2 have a loss of S1P in lymph while maintaining normal plasma S1P. In Lyve-1 Cre+ Sphk-deficient mice, lymphocyte egress from LNs and Peyer's patches is blocked. Treatment with pertussis toxin to overcome Galphai-mediated retention signals restores lymphocyte egress. Furthermore, in the absence of lymphatic Sphks, the initial lymphatic vessels in nonlymphoid tissues show an irregular morphology and a less organized vascular endothelial cadherin distribution at cell-cell junctions. Our data provide evidence that lymphatic endothelial cells are an in vivo source of S1P required for lymphocyte egress from LNs and Peyer's patches, and suggest a role for S1P in lymphatic vessel maturation. .

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Efficiency of Lyve-1 CRE-mediated gene deletion and S1P metabolic enzyme expression in LECs. (A) Isolation and identification of LECs. LNs were minced and digested as detailed in Materials and methods. CD31 and gp38 expression allows separation of LECs from other CD45− cells: FRCs, BECs, and double-negative stromal cells (Others). (left plot) LYVE-1 on indicated populations; (right plots) Control stains for each cell type. (B) Flow cytometric analysis of YFP in cells isolated from LNs of Lyve-1 Cre+ Rosa26-YFP reporter mice (percentages are shown). The four cell populations are gated according to the scheme in A. Peripheral LNs (pLN; axillary, brachial, and inguinal nodes) and mesenteric LNs (mLN) are shown. The shaded histogram represents Cre-negative cells. (C) Immunofluorescence analysis of YFP in LNs of Lyve-1 Cre+ or Rosa26-YFP mice that had been reconstituted with wild-type BM. Fixed LN sections were stained as indicated. Data in A–C are representative of at least three experiments with one to two mice of each type per experiment. (D) Quantitative RT-PCR analysis of S1P metabolic genes in cells sorted from a pool of peripheral and mesenteric LNs using the scheme in A and from spleen tissue or splenic B cells. Data are representative of three separate sorts with 10–15 mice in each sort, with each gene expression measured at least twice. Bars represent means.
Figure 2.
Figure 2.
Ablation of lymph S1P by conditional deletion of Sphk1 in Sphk2-deficient mice. (A) Flow cytometric analysis showing S1P1 on CD4+ CD62Lhi T cells from the indicated circulatory fluids and tissues. Δ indicates Lyve-1 Cre+ Sphk1f/− or f/f Sphk2−/− mice; C indicates littermate control. The shaded histograms show staining with control antibody of cells from LN and blood. Bld, blood; Lym, lymph; Spl, spleen. (B) Measurement of S1P level by bioassay. Lymph fluid and plasma samples were prepared (see Materials and methods) and titrated onto WEHI231 cells expressing FLAG-S1P1. The x axis shows dilution of the samples. The y axis indicates mean fluorescence intensity (MFI) of FLAG antibody staining. Data are representative of at least five experiments with one to two mice each.
Figure 3.
Figure 3.
Lack of contribution of myeloid cells to lymph S1P. (A) Flow cytometric analysis of enzyme-digested LN cells to detect CD11b and CD11c. (B) LYVE-1 or control antibody staining of the six cell populations shown in A. (C) The proportion of each subpopulation replaced by donor-derived cells in lethally irradiated CD45.2+ Lyve-1 Cre+ Sphk-deficient mice reconstituted with wild-type CD45.1+ BM. Numbers refer to the percentage of cells in the indicated gates. (D) S1P1 on CD4+ CD62Lhi T cells from the lymph and LNs of mice that had been reconstituted with wild-type BM as in C. Sphk Δ indicates the Lyve-1 Cre+ Sphk-deficient host; C indicates the control host. The shaded histogram shows staining of LN cells from an FTY720-treated mouse. (E) Bioassay measurement of S1P in lymph and plasma from the chimeric mice. Data in A–E are representative of three experiments with three mice. MFI, mean fluorescence intensity.
Figure 4.
Figure 4.
Impaired lymphocyte egress in Lyve-1 Cre Sphk-deficient mice. (A–E) Cell numbers in the indicated fluids and tissues in Lyve-1 Cre+ Sphk-deficient and control mice. The LN count was from a pool of two axillary, brachial, and inguinal LNs. Enumerated CD4+, CD8+, and CD19+ cells were CD62Lhi. Points indicate data from individual mice, and white (control mice) and black (Sphk-deficient mice) bars represent means. (F) S1P1 on CD4+ CD62Lhi T cells from the indicated tissues. Shaded histograms show staining with control antibody. The vertical dashed lines mark the peak S1P1 intensity in the LN sample to allow comparison. Data in A–F are representative of at least three experiments with one to two mice per experiment. (G and H) Immunohistochemial analysis of LNs (G) and Peyer's patches (H) stained for LYVE-1 (brown) and CD3 (blue) or B220 (blue).
Figure 5.
Figure 5.
PTX treatment facilitates lymphocyte egress and localization in cortical sinuses in Lyve-1 Cre+ Sphk-deficient mice. (A–C) Splenocytes were treated with either PTX or OB and cotransferred into recipient hosts. 22 h later, transferred cell numbers were determined in the lymph and LNs of Lyve-1 Cre+ Sphk-deficient (Sphk Δ) and control hosts. (A) Flow cytometric analysis of transferred T cells present in the lymph. PTX-treated cells were CFSE labeled. Numbers refer to the percentage of cells in the indicated gates. (B) Frequency of transferred OB (O)- and PTX (P)-treated cells in peripheral LNs (pLN), mesenteric LNs (mLN), and the lymph (Lym). (C) Total numbers of transferred CD4 and CD8 T cells in the lymph of control and Sphk-deficient recipients from the same experiments as in B. In B and C, points indicate data from individual mice, and bars indicate means. (D) Distribution of transferred OB- and PTX-treated cells with respect to LN cortical sinuses. Purified T cells were treated and cotransferred into control or Sphk Δ hosts as in A–C. Sections were stained for LYVE-1 (brown) and transferred T cells (blue). Several transferred cells located within sinuses of the Sphk-deficient recipient are marked by arrows. Data in A–D are representative of at least three experiments with one to two mice per experiment. C, control; Δ, Sphk deficient.
Figure 6.
Figure 6.
Lymphatic Sphk expression is required for normal lymphatic vessel maturation. (A) Confocal images showing lymphatic vessels stained with antibody against LYVE-1 in whole mount of mouse trachea. Arrowheads point to the jagged appearance of the lymphatic vessels in Lyve-1 Cre+ Sphk-deficient mice. (B) Confocal images showing the button-like pattern of VE-cadherin at endothelial cell–cell junctions of the diaphragm initial lymphatics. Arrowheads mark VE-cadherin+ buttons in the control and a corresponding junctional region in the Lyve-1 Cre+ Sphk-deficient mice. White squares (top) indicate enlarged regions (bottom). Data are representative of six experiments (n = 6 mice). (C) VE-cadherin buttons per 1,000-µm2 projected area of lymphatic for littermate control and lymphatic Sphk-deficient trachea (n = 3 mice per group). Bars show means ± SE. *, P < 0.05 (Student's t test).
See this image and copyright information in PMC

References (VSports注册入口)

    1. Azzali G. 2003. Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue. Immunol. Rev. 195:178–189 10.1034/j.1600-065X.2003.00072.x - DOI - PubMed
    1. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., Jeltsch M., Petrova T.V., Pytowski B., Stacker S.A., et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115:247–257 - PMC - PubMed
    1. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E., McDonald D.M. 2007. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204:2349–2362 10.1084/jem.20062596 - DOI - PMC - PubMed
    1. Camerer E., Regard J.B., Cornilissen I., Srinivasan Y., Duong D.N., Palmer D., Pham T.H., Wong J.S., Pappu R., Coughlin S.R. 2009. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119:1871–1879 - PMC - PubMed
    1. Gordon E.J., Gale N.W., Harvey N.L. 2008. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev. Dyn. 237:1901–1909 10.1002/dvdy.21605 - DOI - PubMed

"VSports手机版" Publication types

MeSH terms